EGFR is found to regulate NAFLD at various stages, starting from steatosis to NASH, and even with regard to fibrosis, while other RTKs discussed, such as AXL, FGFR4 and VEGFR, are also found to be effective in regulating different manifestations of NAFLD. This evidence concerns the gene EGFR and metabolic dysfunction-associated steatohepatitis.